Article citationsMore>>

Bawa, R. (2013) FDA and Nanotech: Baby Steps Lead to Regulatory Uncertainty. In: Bagchi, D., Bagchi, M., Moriyama, F. and Shahidi, F., Eds., Bio-Nanotechnology: A Revolution in Food, Biomedical and Health Science, John Wiley & Sons, Ltd., New York, 720-732.
https://doi.org/10.1002/9781118451915.ch41

has been cited by the following article:

• TITLE: Statistical Approach to Regulation of Nanotechnology: Need, Advantages and Disadvantages

  AUTHORS: Ricardo Santana Cabello, José Vega-Baudrit, Robin Zuluaga, Piedad Gañán

  KEYWORDS: Nanotechnology, Regulation, Security, Consumer

  JOURNAL NAME: Journal of Biomaterials and Nanobiotechnology, Vol.11 No.1, November 18, 2019

  ABSTRACT: The need to have an express regulation covering nanotechnology has been the subject of debate in the scientific literature and identified as one of the main subsets of nanotechnology field research. However, most countries still do not have regulatory framework in order to guarantee consumer safety. This is the case of Costa Rica, one of the most promising countries in Latin America in terms of biotechnology and nanotechnology. This article presents a statistical study about the position of industry, academia and government institutions on the need to expressly regulate nanotechnology in Costa Rica. A qualitative study consisting of a survey of 79 forms was done to individuals representing the community involved with nanotechnology and institutions responsible for ensuring the safety of the citizen’s health, to conclude that the nanotechnology regulation should be created to protect the consumer in Costa Rica. The research also proposes aspects that should be taken into account in its drafting as well as the variables on which decisions should be made to authorize the commercialization of nanomaterials based on the findings of the literature.